The U.S. Patient Survival Report displays an estimate of the number of patients who are alive after a bone marrow or umbilical cord blood transplant. The estimates are shown:
- By disease and length of time after transplant: 100 days, 1 year, and 3 years
- By the type of donor who provided the cells for transplant:
- Autologous (the patient's cells)
- Related allogeneic (a patient's sibling or another family member's cells)
- Unrelated allogeneic (a volunteer donor's cells)
The cells used for transplant can be from bone marrow, peripheral blood, or umbilical cord blood after a baby is born.
Choose the information for your report and then click Continue.
(To change a selection, use Previous Step.)
